Latest in People and Business News
The latest happenings in the industry from the past month, all in one place.
People News
Worldwide Clinical Trials, Inc. announced that Mike Mencer has joined the company as the EVP and General Manager of Worldwide’s Early Phase Services, focusing on the Bioanalysis Lab in Austin, Texas, and the Clinical Pharmacology Unit clinic in San Antonio, Texas.
Signant Health is proud to announce the appointment of Ian Jennings as Chief Commercial Officer.
Abond CRO announced that Susan Walker is a member of its Board of Directors.
CTI Clinical Trial and Consulting Services announced the promotions of Hadley Decker and Chris Kaas to Director of Global Training & Development and Director of Information Technology, respectively.
Business News
Almac Clinical Services announced its Just in Time Manufacturing processes have received GMP compliance certification from Ireland’s Health Products Regulatory Authority.
Signant Health is proud to announce that it has officially opened a new office facility in Blue Bell, Pennsylvania.
Spaulding Clinical Research announced that it has been awarded a five-year contract with the U.S. Food and Drug Administration Division of Applied Regulatory Science to conduct multiple clinical trials in various therapeutic areas of interest.
Clinerion partners their Patient Network Explorerwith iClusion’s Trial Eye platforms to boost the identification and recruitment of more patients into clinical trials.
Clinerion has also announced that it has gained ISO 27001:2013 certification.
Recognition
PPD, Inc. has been named to Training magazine’s 2020 Training Top 125 list.
Novotech has been recognized by the Workplace Gender Equality Agency as a WGEA Employer of Choice for Gender Equality.
CROMSOURCE announced a milestone in digital management of its projects in cooperation with TECHORIZON-initiating the 1,000th trial to be managed within TheClinical digital environment.
Celerion celebrates 10 years of industry leadership providing early clinical research services to the biopharmaceutical industry.
TARGET PharmaSolutions Inc. announced the launch of its seventh observational cohort study, TARGET-ASTHMA.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
